LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy

Abstract Tumor‐associated macrophages (TAMs) greatly contribute to immune checkpoint inhibitor (ICI) resistance of cancer. However, its underlying mechanisms and whether TAMs can be promising targets to overcome ICI resistance remain to be unveiled. Through integrative analysis of immune multiomics...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Liang Wang, Jieyi Fan, Sifan Wu, Shilin Cheng, Junlong Zhao, Fan Fan, Chunchen Gao, Rong Qiao, Qiqi Sheng, Yiyang Hu, Yong Zhang, Pengjun Liu, Zhe Jiao, Tiaoxia Wei, Jie Lei, Yan Chen, Hongyan Qin
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2024-10-01
Colección:	iMeta
Materias:	immune checkpoint LTBR myeloid derived suppressor cells CD8+ T cells tumor‐associated macrophages
Acceso en línea:	https://doi.org/10.1002/imt2.233
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

LTBR acts as a novel immune checkpoint of tumor‐associated macrophages for cancer immunotherapy

Ejemplares similares